pharmaceutical investing AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma 03 September
pharmaceutical investing AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference 03 September
